Phibro Animal Health (PAHC) Price Target Raised to $36.00 at Morgan Stanley

Phibro Animal Health (NASDAQ:PAHC) had its price objective boosted by Morgan Stanley from $30.00 to $36.00 in a research note released on Wednesday morning. The brokerage currently has an underweight rating on the stock.

Other equities research analysts have also issued reports about the company. Piper Jaffray Companies reissued a buy rating and set a $42.00 price target on shares of Phibro Animal Health in a research report on Friday, November 10th. Zacks Investment Research raised Phibro Animal Health from a hold rating to a buy rating and set a $41.00 price target on the stock in a research report on Tuesday, October 31st. ValuEngine lowered Phibro Animal Health from a buy rating to a hold rating in a research report on Thursday, November 9th. Credit Suisse Group upped their price target on Phibro Animal Health from $37.00 to $39.00 and gave the company a neutral rating in a research report on Tuesday. Finally, BidaskClub raised Phibro Animal Health from a strong sell rating to a sell rating in a research report on Thursday, December 21st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $38.20.

Shares of Phibro Animal Health (PAHC) opened at $36.60 on Wednesday. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.85 and a current ratio of 3.12. The stock has a market capitalization of $1,460.65, a P/E ratio of 23.01, a P/E/G ratio of 3.97 and a beta of 1.18. Phibro Animal Health has a 52-week low of $26.70 and a 52-week high of $40.25.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings results on Monday, February 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.06. The business had revenue of $205.90 million for the quarter, compared to analyst estimates of $194.90 million. Phibro Animal Health had a return on equity of 40.49% and a net margin of 7.90%. The business’s revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.39 EPS. research analysts predict that Phibro Animal Health will post 1.69 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be given a $0.10 dividend. This represents a $0.40 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Tuesday, March 6th. Phibro Animal Health’s dividend payout ratio is presently 26.14%.

Hedge funds and other institutional investors have recently modified their holdings of the business. First Manhattan Co. acquired a new stake in Phibro Animal Health in the fourth quarter worth $100,000. Dean Capital Investments Management LLC acquired a new stake in Phibro Animal Health in the fourth quarter worth $200,000. Susquehanna International Group LLP acquired a new stake in Phibro Animal Health in the second quarter worth $219,000. Teacher Retirement System of Texas acquired a new stake in Phibro Animal Health in the fourth quarter worth $224,000. Finally, Crossmark Global Holdings Inc. acquired a new stake in Phibro Animal Health in the fourth quarter worth $253,000. 48.31% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Phibro Animal Health (PAHC) Price Target Raised to $36.00 at Morgan Stanley” was published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright law. The correct version of this story can be read at https://sportsperspectives.com/2018/02/08/phibro-animal-health-pahc-price-target-raised-to-36-00-at-morgan-stanley.html.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply